What does Apple Tree Partners do?

Apple Tree Partners (ATP) is a life sciences venture capital firm established in 1999. The firm focuses on creating, incubating, and investing in biotechnology companies that aim to develop innovative therapeutics for diseases such as cancer, neurological disorders, and infectious diseases. With over 25 years of experience and $2.65 billion in committed capital, ATP has a strong track record in managing funds that have performed well in the market. ATP operates from offices in New York, London, San Francisco, and Cambridge, MA. The firm supports companies from early-stage ideas through to IPOs by providing flexible capital, strategic insights, and operational resources. In 2022, ATP launched ATP R&D Labs in New Haven, Connecticut, which serves as an incubator and accelerator, offering services like compound screening and preclinical pharmacology. ATP has invested in a variety of companies, including Deep Apple Therapeutics and Aileron Therapeutics, focusing on drug discovery platforms and advancements in oncology, neurology, and infectious diseases.